517 related articles for article (PubMed ID: 30103789)
1. Dual effect of DLBCL-derived EXOs in lymphoma to improve DC vaccine efficacy in vitro while favor tumorgenesis in vivo.
Chen Z; You L; Wang L; Huang X; Liu H; Wei JY; Zhu L; Qian W
J Exp Clin Cancer Res; 2018 Aug; 37(1):190. PubMed ID: 30103789
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of Anti-Leukemia Immunity by Leukemia-Derived Exosomes Via Downregulation of TGF-β1 Expression.
Huang F; Wan J; Hu W; Hao S
Cell Physiol Biochem; 2017; 44(1):240-254. PubMed ID: 29130994
[TBL] [Abstract][Full Text] [Related]
3. Tumor-derived exosomes elicit tumor suppression in murine hepatocellular carcinoma models and humans in vitro.
Rao Q; Zuo B; Lu Z; Gao X; You A; Wu C; Du Z; Yin H
Hepatology; 2016 Aug; 64(2):456-72. PubMed ID: 26990897
[TBL] [Abstract][Full Text] [Related]
4. Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer.
Huang L; Rong Y; Tang X; Yi K; Qi P; Hou J; Liu W; He Y; Gao X; Yuan C; Wang F
Mol Cancer; 2022 Feb; 21(1):45. PubMed ID: 35148751
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cell-derived exosomes elicit tumor regression in autochthonous hepatocellular carcinoma mouse models.
Lu Z; Zuo B; Jing R; Gao X; Rao Q; Liu Z; Qi H; Guo H; Yin H
J Hepatol; 2017 Oct; 67(4):739-748. PubMed ID: 28549917
[TBL] [Abstract][Full Text] [Related]
6. Exosomes from heat-stressed tumour cells inhibit tumour growth by converting regulatory T cells to Th17 cells via IL-6.
Guo D; Chen Y; Wang S; Yu L; Shen Y; Zhong H; Yang Y
Immunology; 2018 May; 154(1):132-143. PubMed ID: 29197065
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive Photoacoustic Imaging of Dendritic Cell Stimulated with Tumor Cell-Derived Exosome.
Piao YJ; Kim HS; Moon WK
Mol Imaging Biol; 2020 Jun; 22(3):612-622. PubMed ID: 31385127
[TBL] [Abstract][Full Text] [Related]
8. Efficient induction of antitumor T cell immunity by exosomes derived from heat-shocked lymphoma cells.
Chen W; Wang J; Shao C; Liu S; Yu Y; Wang Q; Cao X
Eur J Immunol; 2006 Jun; 36(6):1598-607. PubMed ID: 16708399
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
da Cunha A; Antoniazi Michelin M; Cândido Murta EF
Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
[TBL] [Abstract][Full Text] [Related]
10. Dendritic cells loaded with exosomes derived from cancer stem cell-enriched spheroids as a potential immunotherapeutic option.
Naseri M; Zöller M; Hadjati J; Ghods R; Ranaei Pirmardan E; Kiani J; Eini L; Bozorgmehr M; Madjd Z
J Cell Mol Med; 2021 Apr; 25(7):3312-3326. PubMed ID: 33634564
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cells recruit T cell exosomes via exosomal LFA-1 leading to inhibition of CD8+ CTL responses through downregulation of peptide/MHC class I and Fas ligand-mediated cytotoxicity.
Xie Y; Zhang H; Li W; Deng Y; Munegowda MA; Chibbar R; Qureshi M; Xiang J
J Immunol; 2010 Nov; 185(9):5268-78. PubMed ID: 20881190
[TBL] [Abstract][Full Text] [Related]
12. Tumor-derived exosomes: the next generation of promising cell-free vaccines in cancer immunotherapy.
Naseri M; Bozorgmehr M; Zöller M; Ranaei Pirmardan E; Madjd Z
Oncoimmunology; 2020 Jun; 9(1):1779991. PubMed ID: 32934883
[TBL] [Abstract][Full Text] [Related]
13. Tumor exosomes block dendritic cells maturation to decrease the T cell immune response.
Ning Y; Shen K; Wu Q; Sun X; Bai Y; Xie Y; Pan J; Qi C
Immunol Lett; 2018 Jul; 199():36-43. PubMed ID: 29800589
[TBL] [Abstract][Full Text] [Related]
14. Exosomes with membrane-associated TGF-β1 from gene-modified dendritic cells inhibit murine EAE independently of MHC restriction.
Yu L; Yang F; Jiang L; Chen Y; Wang K; Xu F; Wei Y; Cao X; Wang J; Cai Z
Eur J Immunol; 2013 Sep; 43(9):2461-72. PubMed ID: 23716181
[TBL] [Abstract][Full Text] [Related]
15. Diffuse large B-cell lymphoma-derived exosomes push macrophage polarization toward M2 phenotype via GP130/STAT3 signaling pathway.
Ling HY; Yang Z; Wang PJ; Sun Y; Ju SG; Li J; Fu JX
Chem Biol Interact; 2022 Jan; 352():109779. PubMed ID: 34922904
[TBL] [Abstract][Full Text] [Related]
16. [Inhibiting effect of IL-10 in tumor microenvironment on anti-tumor activity of SOCS1-silenced DC vaccine].
Wang Z; You H; Song S
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Apr; 29(4):379-83. PubMed ID: 23643168
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor gene-engineered J558 tumor cell-released exosomes stimulate tumor antigen P1A-specific CD8+ CTL responses and antitumor immunity.
Xie Y; Bai O; Zhang H; Li W; Xiang J
Cancer Biother Radiopharm; 2010 Feb; 25(1):21-8. PubMed ID: 20187793
[TBL] [Abstract][Full Text] [Related]
18. Microenvironmental oxygen pressure orchestrates an anti- and pro-tumoral γδ T cell equilibrium via tumor-derived exosomes.
Li L; Cao B; Liang X; Lu S; Luo H; Wang Z; Wang S; Jiang J; Lang J; Zhu G
Oncogene; 2019 Apr; 38(15):2830-2843. PubMed ID: 30546089
[TBL] [Abstract][Full Text] [Related]
19. Glycosyl-phosphatidylinositol-anchored interleukin-2 expressed on tumor-derived exosomes induces antitumor immune response in vitro.
Zhang J; Zhang Y; Luo C; Xia Y; Chen H; Wu X
Tumori; 2010; 96(3):452-9. PubMed ID: 20845808
[TBL] [Abstract][Full Text] [Related]
20. Exosomes from Dendritic Cells Loaded with Chaperone-Rich Cell Lysates Elicit a Potent T Cell Immune Response Against Intracranial Glioma in Mice.
Bu N; Wu H; Zhang G; Zhan S; Zhang R; Sun H; Du Y; Yao L; Wang H
J Mol Neurosci; 2015 Jul; 56(3):631-43. PubMed ID: 25680514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
